US2007059772A1PendingUtilityA1
Phosphorylated glyoxalase I and its use
Assignee: VLAAMS INTERUNIV INST BIOTECHPriority: Jan 31, 2001Filed: Nov 14, 2006Published: Mar 15, 2007
Est. expiryJan 31, 2021(expired)· nominal 20-yr term from priority
Inventors:Katia Vancompernolle
C12N 9/88
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a phosphorylated form of mammalian glyoxalase I. The present invention relates further to the use of phosphorylated mammalian glyoxalase I to modulate MG-modification of proteins (AGE formation) and consequent cell death, especially upon stress such as oxidative stress, or upon TNF treatment.
Claims
exact text as granted — not AI-modified1 .- 11 . (canceled)
12 . A process for modulating methylglyoxal-modification of proteins in a cell, said process comprising:
contacting the cell with a means for phosphorylating a glyoxalase I associated with the cell.
13 . The process of claim 12 , wherein the means for phosphorylating a glyoxalase I is selected from the group consisting of TNF, PKA, a phosphorylation mutant of glyoxalase I, and combinations of any thereof.
14 . The process of claim 12 , wherein the means for phosphorylating a glyoxalase I is TNF.
15 . The process of claim 12 , wherein the glyoxalase I is mammalian glyoxalase I.
16 . The process of claim 12 , wherein the glyoxalase I comprises an amino acid sequence of SEQ ID NO: 1.
17 . The process of claim 12 , wherein the modulation of the methylglyoxal-modification of proteins occurs in a cell.
18 . (canceled)Join the waitlist — get patent alerts
Track US2007059772A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.